See more : Lianlian DigiTech Co Ltd (2598.HK) Income Statement Analysis – Financial Results
Complete financial analysis of GNCC Capital, Inc. (GNCP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of GNCC Capital, Inc., a leading company in the Gold industry within the Basic Materials sector.
You may be interested
- The Landis Taipei Hotel Co., Ltd (5703.TWO) Income Statement Analysis – Financial Results
- Delegat Group Limited (DGL.NZ) Income Statement Analysis – Financial Results
- Biosergen AB (BIOSGN.ST) Income Statement Analysis – Financial Results
- Energiedienst Holding AG (0QOH.L) Income Statement Analysis – Financial Results
- Salisbury Bancorp, Inc. (SAL) Income Statement Analysis – Financial Results
GNCC Capital, Inc. (GNCP)
About GNCC Capital, Inc.
GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 6.13K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 6.13K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 555.45K | 595.20K | 1.12M | 649.79K | 674.88K | 654.88K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 555.45K | 595.20K | 1.12M | 649.79K | 674.88K | 654.88K |
| Cost & Expenses | 555.45K | 595.20K | 1.12M | 649.79K | 674.88K | 654.88K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 3.41M | 3.40M | 3.55M |
| Depreciation & Amortization | -4.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -555.45K | -595.20K | -1.11M | -649.79K | -674.88K | -654.88K |
| EBITDA Ratio | 0.00% | 0.00% | -18,101.17% | 0.00% | 0.00% | 0.00% |
| Operating Income | -555.45K | -595.20K | -1.11M | -649.79K | -674.88K | -654.88K |
| Operating Income Ratio | 0.00% | 0.00% | -18,101.17% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -4.00 | 1.00 | -2.44M | -3.41M | -3.40M | -3.55M |
| Income Before Tax | -555.45K | -595.20K | -3.55M | -4.06M | -4.08M | -4.20M |
| Income Before Tax Ratio | 0.00% | 0.00% | -57,928.10% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -555.45K | -595.20K | -3.55M | -4.06M | -4.08M | -4.20M |
| Net Income Ratio | 0.00% | 0.00% | -57,928.10% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 69.92B | 35.91B | 35.91B | 17.41B | 17.41B | 17.41B |
| Weighted Avg Shares Out (Dil) | 69.92B | 35.91B | 35.91B | 17.41B | 17.41B | 17.41B |
No news found for: GNCP
Source: https://incomestatements.info
Category: Stock Reports